DYME

DRUG2 trials

Sponsors

Aqumen Biopharmaceuticals, N.A.

Conditions

Mature Cataracts

Phase 3

DY001: Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract Surgery

CompletedNCT00596583

Aqumen Biopharmaceuticals, N.A.Mature Cataracts

Start: 2007-04-30End: 2008-05-31Target: 300Updated: 2009-03-02

DY002: Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract Surgery

TerminatedNCT00596492

Aqumen Biopharmaceuticals, N.A.Mature Cataracts

Start: 2008-05-31End: 2008-12-31Target: 200Updated: 2009-03-02